Around 60 children and young people each year will benefit from Pedmarqsi. A groundbreaking treatment to prevent hearing loss in children having cancer treatment is to be used in the NHS (Alamy/PA ...
Anhydrous sodium thiosulfate, also known as Pedmarqsi and made by Norgine, is recommended in final draft guidance for preventing hearing loss caused by cisplatin chemotherapy in children from the ages ...
The latest bulk procurement included some 11,000 cochlear implants purchased from five suppliers, as well as 258,000 peripheral vascular stents obtained from 18 suppliers, the National Healthcare ...
A “groundbreaking” drug which helps to prevent hearing loss among children undergoing cancer treatment has been given the green light for NHS use. Chemotherapy drug cisplatin is widely used to ...